UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
Clinical trial NCT05535413 · RECRUITING
Trial details
- NCT number
- NCT05535413
- Sponsor
- Hunan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2024-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.